I imagine this one will start to move again as the time of trial commencement approaches....worth a punt IMHOP
AnnaP
Sydney - Friday - November 8: (RWE) - Ventracor Ltd today
announced it was planning to seek approval before the end of November to
begin human implant trials of its VentrAssist heart assist device.
Managing director and CEO Mr Michael Spooner told the annual
meeting that Ventracor was in the final stages of collecting data to
support its submissions to the Ethics Committee of The Alfred hospital
in Melbourne, where the first series of implants would be performed.
"Once the submission to the Ethics Committee is completed, we
will work closely in support of The Alfred hospital and its surgical
team, led by Professor Don Esmore, in preparing for the forthcoming
clinical trial.
"With the best currently available information and recognising
that The Alfred team is responsible for the conduct of the clinical
trial, it is expected that the lead-up process to commence human
implants may take eight to 10 weeks," Mr Spooner said.
"Ventracor has sufficient funds to undertake the Pilot Trial in
Australia and to commence our global Pivotal Trial.
"Ventracor is well positioned to improve the quality of life for
hundreds of thousands of people worldwide suffering heart failure by
obtaining a significant share of the massive heart assist market, which
is expected to grow between $US7.5 billion and $US12 billion in the next
few years", he said.
Shares in Ventracor fell 1c to 81c.
- Forums
- ASX - By Stock
- VCR
- Ventracor trials to commence shortly
VCR
ventracor limited
Ventracor trials to commence shortly
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VCR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online